Disruptive Pharma AB (FRA:5LH0) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5LH0 Disruptive Pharma AB FRA:5LH0
4 GF Score
Price €0.09
View Full Analysis

What is Disruptive Pharma AB FFO per Share?

FFO per Share only applies to REITs.

FRA:5LH0
4GF Score
Disruptive Pharma AB FRA:5LH0
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disruptive Pharma AB Business Description

Comparable Companies
Other Exchanges DPHA:Sweden
Address Dag Hammarskjold Road 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Disruptive Pharma AB is a Swedish drug delivery technology company developing and commercializing Formulite, a patented platform based on mesoporous magnesium carbonate (MMC). The platform is designed to improve the solubility, oral bioavailability and other properties of pharmaceutical compounds. The company's business model is based on contract development, partnerships and licensing arrangements with pharmaceutical and biotechnology companies for the development and commercialization of drug products optimized with Formulite.
4GF Score

Get the complete analysis for FRA:5LH0

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price